Stover D M, Carey I, Garzon R J, Zehner Z E
Department of Biochemistry and Molecular Biophysics, Medical College of Virginia/Virginia Commonwealth University, Richmond 23298.
Cancer Res. 1994 Jun 15;54(12):3092-5.
The intermediate filament protein, vimentin, is differentially expressed in various tissues and stages of development and in metastatic versus nonmetastatic breast cancer cell lines. Previously, we have shown vimentin expression to be regulated at least in part by a silencer element which binds a M(r) 95,000 protein and an overriding, antisilencer element which binds a M(r) 140,000 protein. Southwestern blot (DNA-protein) analyses indicate that silencer protein binding activity is missing in the metastatic breast cancer cell line (MDA-MB-231), where vimentin is highly expressed, but is present in the nonmetastatic breast cancer cell line, MCF-7, where vimentin is not expressed. This suggests that the absence of a functional silencer protein may lead to expression of vimentin as well as other genes which contribute to the metastatic state.
中间丝蛋白波形蛋白在不同组织、发育阶段以及转移性和非转移性乳腺癌细胞系中差异表达。此前,我们已表明波形蛋白的表达至少部分受一个与95,000分子量蛋白结合的沉默子元件以及一个与140,000分子量蛋白结合的主导性反沉默子元件调控。蛋白质印迹(DNA-蛋白质)分析表明,在波形蛋白高表达的转移性乳腺癌细胞系(MDA-MB-231)中,沉默子蛋白结合活性缺失,但在不表达波形蛋白的非转移性乳腺癌细胞系MCF-7中存在。这表明功能性沉默子蛋白的缺失可能导致波形蛋白以及其他促成转移状态的基因的表达。